Clinical response to hypertensive hypervolemic therapy and outcome after subarachnoid hemorrhage

Neurosurgery

Volumn 66, Issue 1, 2010, Pages 35-41

  Frontera, Jennifer A ^a   Fernandez, Andres ^b   Schmidt, J Michael ^b   Claassen, Jan ^b   Wartenberg, Katja E ^b   Badjatia, Neeraj ^b   Connolly, E Sander ^b   Mayer, Stephan A ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b College of Physicians and Surgeons ^*  (United States)

Author keywords

Angioplasty; Hypertensive hypervolemic therapy; Outcome; Subarachnoid hemorrhage; Triple H; Vasospasm

Indexed keywords

ALBUMIN; HYPERTENSIVE AGENT;

ADULT; ANEURYSM SURGERY; ARTICLE; BRAIN INFARCTION; BRAIN VASOSPASM; CLINICAL ASSESSMENT; COMPUTER ASSISTED TOMOGRAPHY; CRYSTALLOID; FEMALE; FLUID RESUSCITATION; HUMAN; HYPERTENSIVE HYPERVOLEMIC THERAPY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RANKIN SCALE; STATISTICAL ANALYSIS; SUBARACHNOID HEMORRHAGE; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; ALBUMINS; COHORT STUDIES; CONFIDENCE INTERVALS; FEMALE; FLUID THERAPY; HUMANS; HYPERTENSION; ISOTONIC SOLUTIONS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SUBARACHNOID HEMORRHAGE; TOMOGRAPHY SCANNERS, X-RAY COMPUTED; TREATMENT OUTCOME; VASOSPASM, INTRACRANIAL; YOUNG ADULT;

EID: 77249100229     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000359530.04529.07     Document Type: Article

References (44)

1. Allen GS, Ahn HS, Preziosi TJ, et al. Cerebral arterial spasm-A controlled trial of nimodipine in patients with subarachnoid hemorrhage. N Engl J Med. 1983;308(11):619-624.
2. Feigin VL, Rinkel GJ, Algra A, Vermeulen M, van Gijn J. Calcium antagonists in patients with aneurysmal subarachnoid hemorrhage: A systematic review. Neurology. 1998;50(4):876-883. (Pubitemid 28212809)
3. Fernandez A, Schmidt JM, Claassen J, et al. Fever after subarachnoid hemorrhage: Risk factors and impact on outcome. Neurology. 2007;68(13):1013- 1019.
4. Oliveira-Filho J, Ezzeddine MA, Segal AZ, et al. Fever in subarachnoid hemorrhage: Relationship to vasospasm and outcome. Neurology. 2001;56(10):1299-1304.
5. Macdonald RL, Kassell NF, Mayer S, et al. and CONSCIOUS 1 Investigators. Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1). Randomized, double-blind, placebocontrolled phase 2 dose-finding trial. Stroke. 2008;39(11):3015-3021.
6. Frontera JA, Rundek T, Schmidt JM, et al. Cerebrovascular reactivity and vasospasm after subarachnoid hemorrhage: A pilot study. Neurology. 66(5):727-729.
7. Lang EW, Diehl RR, Mehdorn HM. Cerebral autoregulation testing after aneurysmal subarachnoid hemorrhage: The phase relationship between arterial blood pressure and cerebral blood flow velocity. Crit Care Med. 2001;29(1):158-163.
8. Soehle M, Czosnyka M, Pickard JD, Kirkpatrick PJ. Continuous assessment of cerebral autoregulation in subarachnoid hemorrhage. Anesth Analg. 2004;98(4):1133-1139.
9. Ferguson GG, Harper AM, Fitch W, Rowan JO, Jennett B. Cerebral blood flow measurements after spontaneous subarachnoid haemorrhage. Eur Neurol. 1972;8(1):15-22.
10. Kosnik EJ, Hunt WE. Postoperative hypertension in the management of patients with intracranial arterial aneurysms. J Neurosurg. 1976;45(2):148-154.
11. Meyer CH, Lowe D, Meyer M, Richardson PL, Neil-Dwyer G. Progressive change in cerebral blood flow during the first three weeks after subarachnoid hemorrhage. Neurosurgery. 1983;12(1):58-76.
12. Muizelaar JP, Becker DP. Induced hypertension for the treatment of cerebral ischemia after subarachnoid hemorrhage. Direct effect on cerebral blood flow. Surg Neurol. 1986;25(4):317-325.
13. Origitano TC, Wascher TM, Reichman OH, Anderson DE. Sustained increased cerebral blood flow with prophylactic hypertensive hypervolemic hemodilution ("triple-H" therapy) after subarachnoid hemorrhage. Neurosurgery. 1990;27(5):729-740.
14. Prunell GF, Mathiesen T, Svendgaard NA. Experimental subarachnoid hemorrhage: Cerebral blood flow and brain metabolism during the acute phase in three different models in the rat. Neurosurgery. 2004;54(2):426-437.
15. Critchley GR, Bell BA. Acute cerebral tissue oxygenation changes following experimental subarachnoid hemorrhage. Neurol Res. 2003;25(5):451-456.
16. Fandino J, Kaku Y, Schuknecht B, Valavanis A, Yonekawa Y. Improvement of cerebral oxygenation patterns and metabolic validation of superselective intraarterial infusion of papaverine for the treatment of cerebral vasospasm. J Neurosurg. 1998; 89(1):93-100.
17. Pritz MB, Giannotta SL, Kindt GW, McGillicuddy JE, Prager RL. Treatment of patients with neurological deficits associated with cerebral vasospasm by intravascular volume expansion. Neurosurgery. 1978;3(3):364-368.
18. Treggiari MM, Walder B, Suter PM, Romand JA. Systematic review of the prevention of delayed ischemic neurological deficits with hypertension, hypervolemia, and hemodilution therapy following subarachnoid hemorrhage. J Neurosurg. 2003;98(5):978-984.
19. Awad IA, Carter LP, Spetzler RF, Medina M, Williams FC Jr: Clinical vasospasm after subarachnoid hemorrhage: Response to hypervolemic hemodilution and arterial hypertension. Stroke. 1987;18(2):365-372.
20. Kassell NF, Peerless SJ, Durward QJ, Beck DW, Drake CG, Adams HP. Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension. Neurosurgery. 1982;11(3):337-343.
21. Liu-Deryke X, Rhoney DH. Cerebral vasospasm after aneurysmal subarachnoid hemorrhage: An overview of pharmacologic management. Pharmacotherapy. 2006;26(2):182-203.
22. Claassen J, Bernardini GL, Kreiter K, et al. Effect of cisternal and ventricular blood on risk of delayed cerebral ischemia after subarachnoid hemorrhage: The Fisher scale revisited. Stroke. 2001;32(9):2012-2020.
23. Hijdra A, van Gijn J, Nagelkerke NJ, Vermeulen M, van Crevel H. Prediction of delayed cerebral ischemia, rebleeding, and outcome after aneurysmal subarachnoid hemorrhage. Stroke. 1988;19(10):1250-1256.
24. Hunt WE, Hess RM. Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg. 1968;28(1):14-20.
25. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: A severity of disease classification system. Crit Care Med. 1985;13(10):818-829.
26. Lawton MP, Brody EM. Assessment of older people: Self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9(3):179-186.
27. Brandt J, Spencer M, Folstein M. The telephone interview for cognitive status. Neuropsychiatry Neuropsychol Behav Neurol. 1988;1(2):111-117.
28. Brandt J, Welsh KA, Breitner JC, Folstein MF, Helms M, Christian JC. Hereditary influences on cognitive functioning in older men. A study of 4000 twin pairs. Arch Neurol. 1993;50(6):599-603.
29. Frontera JA, Fernandez A, Claassen J, et al. Hyperglycemia after SAH: Predictors, associated complications, and impact on outcome. Stroke. 2006;37(1):199-203.
30. Bejjani GK, Bank WO, Olan WJ, Sekhar LN. The efficacy and safety of angioplasty for cerebral vasospasm after subarachnoid hemorrhage. Neurosurgery. 1998;42(5):979-987.
31. Eskridge JM, McAuliffe W, Song JK, et al. Balloon angioplasty for the treatment of vasospasm: Results of first 50 cases. Neurosurgery. 1998;42(3):510-517.
32. Firlik AD, Kaufmann AM, Jungreis CA, Yonas H. Effect of transluminal angioplasty on cerebral blood flow in the management of symptomatic vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg. 1997;86(5):830-839.
33. Jestaedt L, Pham M, Bartsch AJ, et al. The impact of balloon angioplasty on the evolution of vasospasm-related infarction after aneurysmal subarachnoid hemorrhage. Neurosurgery. 2008;62(3):610-617.
34. Rosenwasser RH, Armonda RA, Thomas JE, Benitez RP, Gannon PM, Harrop J. Therapeutic modalities for the management of cerebral vasospasm: Timing of endovascular options. Neurosurgery. 1999;44(5):975-980.
35. Egge A, Waterloo K, Sjoholm H, Solberg T, Ingebrigtsen T, Romner B. Prophylactic hyperdynamic postoperative fluid therapy after aneurysmal subarachnoid hemorrhage: A clinical, prospective, randomized, controlled study. Neurosurgery. 2001;49(3):593-606.
36. Lennihan L, Mayer SA, Fink ME, et al. Effect of hypervolemic therapy on cerebral blood flow after subarachnoid hemorrhage: A randomized controlled trial. Stroke. 2000;31(2):383-391.
37. Tohgi H, Yamanouchi H, Murakami M, Kameyama M. Importance of the hematocrit as a risk factor in cerebral infarction. Stroke. 1978;9(4):369-374.
38. Muench E, Horn P, Bauhuf C, et al. Effects of hypervolemia and hypertension on regional cerebral blood flow, intracranial pressure, and brain tissue oxygenation after subarachnoid hemorrhage. Crit Care Med. 2007;35(8):1844-1852.
39. Kiyohara Y, Fujishima M, Ishitsuka T, Tamaki K, Sadoshima S, Omae T. Effects of hematocrit on brain metabolism in experimentally induced cerebral ischemia in spontaneously hypertensive rats (SHR). Stroke. 1985;16(5):835-840.
40. Stone HO, Thompson HK Jr, Schmidt-Nielsen K. Influence of erythrocytes on blood viscosity. Am J Physiol. 1968;214(4):913-918.
41. Tu YK, Heros RC, Candia G, et al. Isovolemic hemodilution in experimental focal cerebral ischemia. Part 1: Effects on hemodynamics, hemorheology, and intracranial pressure. J Neurosurg. 1988;69(1):72-81. (Pubitemid 18160367)
42. Tu YK, Heros RC, Karacostas D, et al. Isovolemic hemodilution in experimental focal cerebral ischemia. Part 2: Effects on regional cerebral blood flow and size of infarction. J Neurosurg. 1988;69(1):82-91. (Pubitemid 18160368)
43. National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network; Wheeler AP, Bernard GR, Thompson BT, et al. Pulmonary-artery versus central venous catheter to guide treatment of acute lung injury. New Engl J Med. 2006;354(21):2213-2224.
44. Bendjelid K, Romand JA. Fluid responsiveness in mechanically ventilated patients: A review of indices used in intensive care. Intensive Care Med. 2003;29(3):352-360.